TY - JOUR
T1 - Assessment of percutaneous endoscopic gastrostomy (PEG) in head and neck cancer patients
AU - Kakuta, Risako
AU - Matsuura, Kazuto
AU - Noguchi, Tetsuya
AU - Kato, Kengo
AU - Katagiri, Katsunori
AU - Imai, Takayuki
AU - Ishida, Eichi
AU - Saijyo, Shigeru
PY - 2011
Y1 - 2011
N2 - As nutrition support for head and neck cancer patients who receive chemoradiotherapy (CRT) and whose oral cavity or pharynx is exposed to radiation, we perform percutaneous endoscopic gastrostomy (PEG) tube placement. We examined 235 patients who underwent PEG in our division between January 2003 and December 2009. For 64% of them, the purpose of performing PEG was nutrition support for CRT, of whom 74% actually used the tube. However, the situation varied according to the primary sites of patients. Forty-four percent of laryngeal cancer patients who underwent PEG actually used the tube, which was a significantly lower rate than others. Also, 81% of them removed the PEG tube within one year. These findings suggest that PEG-tube placement for nutrition support is not indispensable for all CRT cases. Therefore, we recommend performing PEG for oral, oropharyngeal, and hypopharyngeal cancer patients.
AB - As nutrition support for head and neck cancer patients who receive chemoradiotherapy (CRT) and whose oral cavity or pharynx is exposed to radiation, we perform percutaneous endoscopic gastrostomy (PEG) tube placement. We examined 235 patients who underwent PEG in our division between January 2003 and December 2009. For 64% of them, the purpose of performing PEG was nutrition support for CRT, of whom 74% actually used the tube. However, the situation varied according to the primary sites of patients. Forty-four percent of laryngeal cancer patients who underwent PEG actually used the tube, which was a significantly lower rate than others. Also, 81% of them removed the PEG tube within one year. These findings suggest that PEG-tube placement for nutrition support is not indispensable for all CRT cases. Therefore, we recommend performing PEG for oral, oropharyngeal, and hypopharyngeal cancer patients.
KW - Chemoradiotherapy (CRT)
KW - Head and neck cancer
KW - Nutritional support
KW - Percutaneous Endoscopic Gastrostomy (PEG)
UR - http://www.scopus.com/inward/record.url?scp=84870256897&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870256897&partnerID=8YFLogxK
U2 - 10.5981/jjhnc.37.433
DO - 10.5981/jjhnc.37.433
M3 - Article
AN - SCOPUS:84870256897
SN - 1349-5747
VL - 37
SP - 433
EP - 438
JO - Japanese Journal of Head and Neck Cancer
JF - Japanese Journal of Head and Neck Cancer
IS - 3
ER -
